CCRN
Cross Country Healthcare, Inc. NASDAQ Listed Oct 25, 2001$13.17
+0.00%
vs $13.17
Mkt Cap $425.5M
52w Low $7.43
75.9% of range
52w High $14.99
50d MA $11.89
200d MA $10.78
P/E (TTM)
-4.5x
EV/EBITDA
23.9x
P/B
1.3x
Debt/Equity
0.0x
ROE
-25.7%
P/FCF
10.6x
RSI (14)
75.00
ATR (14)
$0.04
Beta
0.34
50d MA
$11.89
200d MA
$10.78
Avg Volume
976.6K
Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.
6551 Park of Commerce Boulevard, N.W. · Boca Raton, FL 33487 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.05 | -0.03 | +40.0% | 13.09 | -0.2% | +0.7% | -0.5% | +0.0% | +0.0% | +0.1% | — |
| Mar 4, 2026 | AMC | 0.03 | -0.06 | -300.0% | 9.13 | -2.0% | +8.3% | -0.7% | +2.4% | -2.1% | -0.7% | — |
| Nov 12, 2025 | AMC | 0.04 | 0.03 | -25.0% | 12.65 | -13.4% | -14.1% | +2.4% | +4.6% | +0.9% | -1.7% | — |
| Aug 6, 2025 | AMC | 0.07 | -0.01 | -114.3% | 13.10 | -2.7% | -4.4% | +1.5% | -0.4% | +0.7% | +2.7% | — |
| May 7, 2025 | AMC | 0.04 | 0.06 | +50.0% | 13.84 | -2.5% | +0.4% | +0.8% | -0.6% | +0.2% | +0.3% | — |
| Mar 5, 2025 | AMC | 0.11 | 0.04 | -63.6% | 16.86 | -0.3% | -6.3% | +0.8% | -0.5% | +0.0% | +0.3% | — |
| Nov 6, 2024 | AMC | 0.10 | 0.12 | +20.0% | 12.15 | +0.2% | +1.0% | -15.6% | +3.8% | +2.6% | -8.4% | — |
| Jul 31, 2024 | AMC | 0.14 | 0.10 | -28.6% | 18.24 | -5.0% | -3.8% | -2.5% | -3.2% | +0.4% | -5.3% | — |
| May 1, 2024 | AMC | 0.17 | 0.19 | +11.8% | 17.90 | -9.9% | -6.5% | -0.4% | -3.9% | +2.6% | +0.2% | — |
| Feb 21, 2024 | AMC | 0.27 | 0.29 | +7.4% | 17.02 | -4.4% | -0.2% | +0.1% | +2.4% | +4.8% | +2.5% | — |
| Nov 1, 2023 | AMC | 0.41 | 0.39 | -4.9% | 23.09 | -30.2% | -13.8% | -2.7% | -3.1% | -1.9% | +1.0% | — |
| Aug 2, 2023 | AMC | 0.61 | 0.69 | +13.1% | 26.50 | -18.3% | -17.0% | -2.7% | +3.7% | +2.4% | +2.4% | — |
| May 3, 2023 | AMC | 0.75 | 0.84 | +12.0% | 21.44 | -4.3% | +4.8% | +4.6% | +0.0% | +5.0% | -1.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 | Wedbush | Upgrade | Neutral → Outperform | — | $8.86 | $9.31 | +5.1% | +5.5% | -1.8% | +4.2% | +1.9% | +0.4% |
| Mar 5 | Benchmark | Upgrade | Hold → Buy | — | $9.13 | $8.95 | -2.0% | +8.3% | -0.7% | +2.4% | -2.1% | -0.7% |
| Dec 9 | UBS | Maintains | Neutral → Neutral | — | $8.14 | $8.17 | +0.4% | -2.3% | +2.6% | +5.5% | -1.4% | -2.8% |
| Jun 17 | Barrington Research | Maintains | Market Perform → Market Perform | — | $13.79 | $13.68 | -0.8% | +1.2% | +2.2% | -1.5% | -5.2% | -1.1% |
| May 13 | UBS | Maintains | Neutral → Neutral | — | $13.92 | $13.92 | +0.0% | +0.2% | +0.3% | -0.3% | +0.3% | -0.4% |
| Mar 14 | Barrington Research | Maintains | Market Perform → Market Perform | — | $15.76 | $15.78 | +0.1% | -1.1% | -1.7% | -2.8% | +0.3% | -0.9% |
| Feb 6 | JMP Securities | Maintains | Market Perform → Market Perform | — | $18.22 | $18.21 | -0.1% | -0.1% | -0.1% | +0.1% | +0.2% | +0.0% |
| Dec 10 | Barrington Research | Downgrade | Outperform → Market Perform | — | $18.06 | $18.06 | +0.0% | +0.1% | -0.2% | +0.1% | +0.0% | -0.7% |
| Dec 5 | Truist | Maintains | Hold → Hold | — | $18.16 | $18.15 | -0.1% | -0.5% | +0.1% | -0.1% | +0.1% | -0.2% |
| Nov 7 | Benchmark | Maintains | Buy → Buy | — | $12.15 | $12.18 | +0.2% | +1.0% | -15.6% | +3.8% | +2.6% | -8.4% |
| Oct 21 | Truist | Maintains | Hold → Hold | — | $12.87 | $12.74 | -1.0% | -6.6% | -0.2% | -1.3% | -0.3% | -2.0% |
| Aug 8 | Barrington Research | Maintains | Outperform → Outperform | — | $15.74 | $15.93 | +1.2% | -0.4% | -2.5% | -6.3% | +0.8% | -2.1% |
| Aug 1 | Truist | Maintains | Hold → Hold | — | $18.24 | $17.32 | -5.0% | -3.8% | -2.5% | -3.2% | +0.4% | -5.3% |
| May 6 | Barrington Research | Maintains | Outperform → Outperform | — | $16.67 | $16.95 | +1.7% | -3.9% | +2.6% | +0.2% | -0.4% | -9.0% |
| May 2 | Benchmark | Maintains | Buy → Buy | — | $17.90 | $16.12 | -9.9% | -6.5% | -0.4% | -3.9% | +2.6% | +0.2% |
| Feb 27 | Barrington Research | Maintains | Outperform → Outperform | — | $17.41 | $17.49 | +0.5% | +4.8% | +2.5% | -2.3% | +0.8% | +0.7% |
| Feb 22 | Truist | Maintains | Hold → Hold | — | $17.02 | $16.27 | -4.4% | -0.2% | +0.1% | +2.4% | +4.8% | +2.5% |
| Feb 22 | Benchmark | Maintains | Buy → Buy | — | $17.02 | $16.27 | -4.4% | -0.2% | +0.1% | +2.4% | +4.8% | +2.5% |
| Nov 29 | Barrington Research | Maintains | Outperform → Outperform | — | $20.72 | $20.89 | +0.8% | -1.5% | -0.7% | +2.0% | +6.6% | -4.7% |
| Nov 3 | Truist | Maintains | Hold → Hold | — | $19.91 | $19.76 | -0.8% | -2.7% | -3.1% | -1.9% | +1.0% | -2.5% |
| Nov 3 | Jefferies | Downgrade | Buy → Hold | — | $19.91 | $19.76 | -0.8% | -2.7% | -3.1% | -1.9% | +1.0% | -2.5% |
| Oct 5 | Jefferies | Maintains | Buy → Buy | — | $25.55 | $25.36 | -0.7% | -3.0% | -4.7% | +3.5% | -2.6% | -2.0% |
| Aug 14 | Barrington Research | Maintains | Outperform → Outperform | — | $23.01 | $23.02 | +0.0% | +2.4% | +3.2% | -2.7% | +1.9% | +3.5% |
| Aug 8 | Credit Suisse | Maintains | Neutral → Neutral | — | $22.19 | $22.14 | -0.2% | +2.4% | +2.4% | -0.4% | -0.7% | +2.4% |
| Jun 1 | Barrington Research | Maintains | Outperform → Outperform | — | $25.50 | $25.47 | -0.1% | +1.2% | +4.5% | -2.7% | +2.1% | +2.3% |
| May 5 | Credit Suisse | Maintains | Neutral → Neutral | — | $22.46 | $22.79 | +1.5% | +4.6% | +0.0% | +5.0% | -1.6% | +1.4% |
| May 2 | Truist | Maintains | Hold → Hold | — | $22.45 | $22.07 | -1.7% | -4.8% | +0.3% | +4.8% | +4.6% | +0.0% |
| Feb 23 | Benchmark | Maintains | Buy → Buy | — | $26.51 | $25.02 | -5.6% | -6.4% | +4.9% | +4.2% | -2.5% | +0.8% |
| Feb 23 | Credit Suisse | Maintains | Neutral → Neutral | — | $26.51 | $25.02 | -5.6% | -6.4% | +4.9% | +4.2% | -2.5% | +0.8% |
| Nov 7 | Barrington Research | Maintains | Outperform → Outperform | — | $32.50 | $32.05 | -1.4% | +2.9% | +1.6% | -2.2% | -0.2% | -7.9% |
| Oct 5 | Truist | Downgrade | Buy → Hold | — | $33.59 | $32.16 | -4.3% | -6.0% | -2.4% | +2.5% | +2.2% | +0.3% |
| Sep 15 | Benchmark | Maintains | Buy → Buy | — | $28.75 | $29.25 | +1.7% | +1.9% | +1.1% | -0.1% | -0.1% | -1.8% |
| Jun 13 | Benchmark | Maintains | Buy → Buy | — | $18.48 | $17.76 | -3.9% | -4.9% | +2.8% | +8.7% | -9.2% | +7.1% |
| Jun 9 | Credit Suisse | Maintains | Neutral → Neutral | — | $18.21 | $18.04 | -0.9% | +2.1% | -0.6% | -4.9% | +2.8% | +8.7% |
| Feb 24 | Benchmark | Maintains | Buy → Buy | — | $21.00 | $20.87 | -0.6% | -1.8% | +13.6% | -4.7% | -4.2% | +4.2% |
| Jan 27 | Jefferies | Upgrade | Hold → Buy | — | $17.92 | $19.33 | +7.9% | +7.3% | +4.8% | +6.7% | +2.2% | +0.8% |
| Aug 16 | Credit Suisse | Maintains | Neutral → Neutral | — | $18.73 | $18.16 | -3.1% | +8.2% | -1.5% | -2.0% | -3.4% | +5.9% |
| Aug 5 | Benchmark | Upgrade | Hold → Buy | — | $16.44 | $18.00 | +9.5% | +24.7% | -6.1% | -0.7% | +1.6% | -0.8% |
| May 6 | Benchmark | Downgrade | Buy → Hold | — | $14.19 | $14.58 | +2.7% | +13.5% | +4.9% | +1.5% | -3.0% | -5.1% |
| May 6 | Credit Suisse | Maintains | Neutral → Neutral | — | $14.19 | $14.58 | +2.7% | +13.5% | +4.9% | +1.5% | -3.0% | -5.1% |
| Feb 25 | Credit Suisse | Maintains | Neutral → Neutral | — | $10.06 | $11.29 | +12.2% | +12.5% | -1.9% | +6.8% | -4.8% | +4.3% |
| Nov 23 | BMO Capital | Upgrade | Market Perform → Outperform | — | $7.72 | $8.24 | +6.7% | +6.3% | +9.0% | +4.1% | +0.8% | -7.3% |
| Nov 5 | BMO Capital | Maintains | Market Perform → Market Perform | — | $7.85 | $9.32 | +18.7% | +0.0% | -6.4% | +9.0% | +1.7% | -5.6% |
| Nov 5 | Credit Suisse | Maintains | Neutral → Neutral | — | $7.85 | $9.32 | +18.7% | +0.0% | -6.4% | +9.0% | +1.7% | -5.6% |
| Nov 5 | Benchmark | Upgrade | Hold → Buy | — | $7.85 | $9.32 | +18.7% | +0.0% | -6.4% | +9.0% | +1.7% | -5.6% |
| Oct 30 | Truist | Upgrade | Hold → Buy | — | $7.13 | $7.65 | +7.3% | +10.1% | +1.3% | +3.9% | -5.0% | +0.0% |
| Aug 6 | Credit Suisse | Maintains | Neutral → Neutral | — | $6.74 | $6.80 | +0.9% | +4.9% | -2.1% | -2.5% | +1.6% | -4.8% |
| May 8 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $6.28 | $6.12 | -2.5% | -8.4% | +9.8% | -6.3% | -13.5% | -7.2% |
| Mar 26 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $8.16 | $8.09 | -0.9% | -8.8% | -16.9% | +2.4% | +6.5% | +7.4% |
| Nov 6 | BMO Capital | Maintains | Market Perform → Market Perform | — | $11.35 | $12.39 | +9.2% | +9.0% | +0.5% | +1.9% | -1.7% | +0.4% |
No insider trades available.
8-K · 1.01
!!! Very High
Cross Country Healthcare, Inc. -- 8-K 1.01: Merger Agreement
Cross Country Healthcare agreed to merge, creating potential shareholder value through a strategic combination that will be determined by the final transaction terms and regulatory approval.
May 7
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on April 17, 2026, disclosing material information to investors under Regulation FD guidelines.
Apr 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CCRN's departure of an executive officer removes potential relationship conflicts but raises questions about leadership stability and operational continuity that investors should monitor.
Mar 30
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The company's technology officer departure signals potential instability in critical infrastructure management, which could delay digital initiatives and warrant scrutiny of replacement candidate qualifications.
Mar 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Leadership transition effective March 10, 2026 could signal strategic direction changes or internal instability, making stock performance dependent on successor credibility and market confidence in continuity.
Mar 10
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare disclosed material information to investors under Regulation FD, ensuring equal access to non-public details across all shareholders simultaneously.
Mar 4
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on February 23, 2026, with details available in the filing exhibit, though the specific announcement content requires reviewing the attached materials for investment impact assessment.
Feb 23
8-K · 7.01
! Medium
Cross Country Healthcare Inc -- 8-K 7.01: Regulation FD Disclosure
Cross Country Healthcare issued a press release on February 12, 2026, disclosing material information to investors through regulatory filing.
Feb 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Boston Partners | 2,545,584 | $24M | Added | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 1,369,654 | $13M | New | Mar 2026 |
| 3 | First Eagle Investment Management, Llc | 1,179,426 | $11M | New | Mar 2026 |
| 4 | Walleye Capital Llc | 1,006,068 | $9M | Added | Mar 2026 |
| 5 | Oddo Bhf Asset Management Sas | 940,000 | $9M | New | Mar 2026 |
| 6 | Dana Investment Advisors, Inc. | 933,217 | $9M | Reduced | Mar 2026 |
| 7 | Fmr Llc | 619,439 | $6M | Added | Mar 2026 |
| 8 | Russell Investments Group, Ltd. | 600,054 | $6M | Added | Mar 2026 |
| 9 | Bank Of America Corp /de/ | 579,937 | $5M | Added | Mar 2026 |
| 10 | Systematic Financial Management Lp | 507,297 | $5M | Reduced | Mar 2026 |
| 11 | Marshall Wace, Llp | 456,996 | $4M | Added | Mar 2026 |
| 12 | Morgan Stanley | 521,522 | $4M | Reduced | Dec 2025 |
| 13 | Vanguard Portfolio Management Llc | 367,192 | $3M | New | Mar 2026 |
| 14 | Citadel Advisors Llc | 305,466 | $3M | Reduced | Mar 2026 |
| 15 | Northern Trust Corp | 270,072 | $3M | Reduced | Mar 2026 |
| 16 | Renaissance Technologies Llc | 245,400 | $2M | Added | Mar 2026 |
| 17 | Prescott Group Capital Management, L.l.c. | 282,910 | $2M | New | Dec 2025 |
| 18 | Jane Street Group, Llc | 233,833 | $2M | Added | Dec 2025 |
| 19 | Qube Research & Technologies Ltd | 151,768 | $1M | Reduced | Mar 2026 |
| 20 | Nierenberg Investment Management Company, Llc | 144,555 | $1M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$425.5M
Enterprise Value
$318.1M
P/E (TTM)
-4.49x
Forward P/E
134.66x
PEG Ratio
-0.00x
P/B
1.32x
P/S
0.40x
P/FCF
10.65x
EV/EBITDA
23.86x
Shares Out
32.4M
Financials (TTM)
Revenue
$1.05B
Net Income
-$94.9M
EBITDA
$13.3M
Free Cash Flow
$40.1M
Op Cash Flow
$48.3M
EPS Basic
$-2.93
EPS Diluted
$-2.93
EPS Forward
$0.10
Gross Margin
18.7%
Op Margin
-0.3%
Net Margin
-9.0%
Balance Sheet
Total Assets
$449.0M
Total Liab.
$126.1M
Total Equity
$322.8M
Cash
$108.7M
LT Debt
$0
Book Value/Sh
$9.96
Debt/Equity
0.01x
Current Ratio
3.78
Quick Ratio
3.78
Returns & Growth
ROE
-25.7%
ROA
-18.5%
ROIC
-0.9%
Rev Growth YoY
-21.6%
EPS Growth YoY
-565.9%
Price Returns
2W
-0.3%
1M
+29.3%
3M
+50.5%
6M
+27.6%
12M
-0.7%
Technicals
52W High
$14.99
52W Low
$7.43
50d MA
$11.89
200d MA
$10.78
RSI (14)
75.00
ATR (14)
$0.04
Beta
0.34
Avg Volume
977K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$10.61
High
$14.00
Low
$8.65
Median
$10.50
Data updated apr 25, 2026 12:25am
· Source: financialmodelingprep.com